Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma
Conditions
- Chronic Lymphocytic Leukemia
- Mantle Cell Lymphoma
- Recurrent Chronic Lymphocytic Leukemia
- Recurrent Mantle Cell Lymphoma
- Recurrent Small Lymphocytic Lymphoma
- Refractory Chronic Lymphocytic Leukemia
- Refractory Mantle Cell Lymphoma
- Refractory Small Lymphocytic Lymphoma
- Small Lymphocytic Lymphoma
Interventions
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Bone Marrow Biopsy
- PROCEDURE: Computed Tomography
- PROCEDURE: Gastrointestinal Endoscopy
- BIOLOGICAL: Rituximab
- DRUG: Sonrotoclax
- DRUG: Zanubrutinib
Sponsor
Fred Hutchinson Cancer Center
Collaborators